Trump administration announces deal to lower weight loss drug prices for many Americans
(WASHINGTON) -- The Trump administration announced deals on Thursday with pharmaceutical giants Novo Nordisk and Eli Lilly that would lower the cost of GLP-1 drugs for many Americans, including those on Medicare.The administration negotiated how much both the government and consumers would pay for the drugs, which are used to treat obesity and diabetes as well as other cardiometabolic conditions.As soon as the public-private partnership TrumpRx launches, patients using the […]